BRÈVE

sur Asia Green Biotechnology Corp. (isin : CA04522C1041)

Asia Green Biotechnology Corp. Announces Filing of Financial Statements on SEDAR

CALGARY, AB / ACCESSWIRE / May 24, 2024 / Asia Green Biotechnology Corp. ("Asia Green" or the "Company") (CSE:ASIA) has announced the filing of several continuous disclosure documents on SEDAR. These include the Annual Audited Financial Statements for the year ended December 31, 2023, Management Discussion & Analysis for the same period, and CEO and CFO certificates.

The filings comply with the requirements of National Instrument 51-102 and National Instrument 52-109. The Company anticipates that the Management Cease Trade Order issued by the Alberta Securities Commission on May 8, 2024, will be lifted following these filings.

Additionally, Asia Green Biotechnology Corp. announced the resignation of Vincent Ghazar from his roles as Chief Financial Officer and Director. Mr. Ghazar will continue to provide consultancy services to the Company in the near term.

R. H.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Asia Green Biotechnology Corp.